Dr. Gary J. Nabel M.D., Ph.D. is Chief Scientific Officer for Global Research and Development at Sanofi.   He also serves as a Senior Vice President and Deputy to the President for Global R&D and in this capacity chairs the Strategic Development and Scientific Advisory Council and Ebola...

Peter Hotez, MD, PhD, is President of the Sabin Vaccine Institute and leads the Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development based at the Baylor College of Medicine in Houston, Texas. He is the Texas Children’s Hospital Endowed Chair of Tropical Pediatrics...

Dr. Stanley A. Plotkin is Emeritus Professor of the University of Pennsylvania, and Adjunct Professor of the Johns Hopkins University. Until 1991, he was Professor of Pediatrics and Microbiology at the University of Pennsylvania, Professor of Virology at the Wistar Institute and at the same...

Dr Rino Rappuoli is currently serves as Chief Scientist at GSK vaccines (previously Novartis Vaccines in Siena, Italy, where his former role was the Global Head of Vaccines Research). Prior to this he was Head of R&D for Sclavo and then Head of Vaccine Research and Chief Scientific Officer for...

Dr. Laura York is currently Vice President, Global Meningococcal Vaccines in the Vaccines Medical Development, Scientific & Clinical Affairs group at Pfizer (PA, USA), and is responsible for the development and execution of the medical strategy for the meningococcal vaccine franchise.  ...

Peter Palese is a United States microbiologist and Professor and Chair of the Department of Microbiology at the Icahn School of Medicine at Mount Sinai in New York City,[1] and an expert in the field of RNA viruses.[2] Palese built "the first genetic maps for influenza A, B and C...

Dr Wellington Sun is a first generation immigrant to the U.S. from Taiwan who has benefitted from the great public school system of New York City in the 1960’s-70’s.  Dr Sun attended Harvard and received a B.A. in physics and chemistry and then a M.D. from the Uniformed Services University of...

Dr. Jérôme Galon is a French biologist and a first class Research Director (DR1) at National Institute of Health and Medical Research (INSERM).He received his Ph.D. degree with specialty in immunology in 1996 and he did his postdoctoral work at the National Institute of Health (NIH), in Bethesda...

James Merson, Ph.D., is Senior Vice President and Chief Scientific Officer of the Vaccine Immunotherapeutics Research Unit, which is based in San Diego and is a member of Pfizer’s Vaccine Research and Development group.  He is accountable for developing both prophylactic vaccines for the prevention ...

Prof Zelig Eshhar, PhD, has pioneered the CAR T cell approach in the late eighties at the Weizmann Institute and further on during a sabbatical year in 1990 at the Surgery Branch with Dr Rosenberg at the NCI adopted it for cancer treatment. Taking advantage of the modular structure of the...

Dr. Steve Projan is the Head of Infectious Diseases & Vaccines Innovative Medicines unit (iMED) at MedImmune, leading a cross-functional team dedicated to the therapeutic area strategy, prioritization and advancement of the company’s infectious disease and vaccine portfolio. Dr. Projan joined...

Dr. Fries, who joined the Novavax team in 2011, has 22 years of experience in the clinical testing and development of human vaccines in academic, small biotech, and major biopharmaceutical environments. While a major career focus has been influenza, he has also had extensive involvement with...

Dr. Ann Ginsberg is Chief Medical Officer at Aeras. In this role, Dr. Ginsberg oversees Aeras’ clinical programs and is a member of its Executive Office. Dr. Ginsberg served as Head, Clinical Development and then Chief Medical Officer at the Global Alliance for TB Drug Development from 2004 to...

Jerome Kim, M.D. Director-General of the International Vaccine Institute (IVI),  is an international expert on the evaluation and development of vaccines. He has strong scientific experience spans basic research through advanced clinical development. A graduate of University of Hawaii (B.A.) and...

Patricia J. Freda Pietrobon, PhD, Associate Vice President, Program Leader C.difficile Vaccine, Sanofi Pasteur, is a Biochemist and Immunochemist by training with over 30 years of experience in leadership roles in the Vaccine & Diagnostic industries. After graduating from Lehigh University...

Mahesh Kumar received his Bachelor of Science degree in Biochemistry from India.  He moved to the United States to pursue his post-graduate education in Microbiology.  He obtained his Master of Science degree from the University of Maine and his Ph.D. from the University of Minnesota in 1990. After ...

Dr. Richard M. Schwartz, Ph.D., is currently the Chief of the Vaccine Production Program (VPP) at the Vaccine Research Center (VRC) at the NIAID/NIH.  Dr. Schwartz has over 25 years experience in pharma and biotech while working in diverse areas including pharmaceutical natural product...